Pembrolizumab,eftilagimod
novartis,Merck
['head and neck', 'immutep', '$immp']
$immp immutep reports final positive data in 2nd line head and neck squamous cell carcinoma at #asco23 
Investor/trader focused primarily in the biopharma sector. 
Tweets are not investment advice and are not recommendations of any kind.